コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dCVF gene therapy has potential for treating retinal degenerative disease.
2 inked to retinitis pigmentosa, a progressive retinal degenerative disease.
3 th use in the treatment of genetic causes of retinal degenerative disease.
4 tation-based approaches for the treatment of retinal degenerative disease.
5 pigment epithelium (RPE) are associated with retinal degenerative disease.
6 transplantation is a potential treatment for retinal degenerative disease.
7 identified in patients with several forms of retinal degenerative disease.
8 st report of a transgenic X. laevis model of retinal degenerative disease.
9 generation of the mammalian retina following retinal degenerative disease.
10 s that BCDO may also be a candidate gene for retinal degenerative disease.
11 in vivo quantitation of retinal structure in retinal degenerative disease.
12 These CD-1 mice do not develop the retinal degenerative disease.
13 while presenting new therapeutic promise for retinal degenerative diseases.
14 eceptors occurs in inherited and age-related retinal degenerative diseases.
15 restoration of sight in patients blinded by retinal degenerative diseases.
16 potential new therapeutic agent for treating retinal degenerative diseases.
17 ntial treatment options for certain blinding retinal degenerative diseases.
18 nal prosthetics offer hope for patients with retinal degenerative diseases.
19 nd for further drug development for treating retinal degenerative diseases.
20 RPE dysfunction plays a significant role in retinal degenerative diseases.
21 , which may be a novel therapeutic target in retinal degenerative diseases.
22 hR2-based gene therapy for treating blinding retinal degenerative diseases.
23 el approach for treating blindness caused by retinal degenerative diseases.
24 rtunity for the development of therapies for retinal degenerative diseases.
25 e have been identified in a variety of human retinal degenerative diseases.
26 a, but they also suggest novel ways to treat retinal degenerative diseases.
27 n in a wide variety of genetically disparate retinal degenerative diseases.
28 velopment of therapeutic approaches to treat retinal degenerative diseases.
29 ses (AAVs) show promise for the treatment of retinal degenerative diseases.
30 volved in the pathology of certain inherited retinal degenerative diseases.
31 ess and detachment in small animal models of retinal degenerative diseases.
32 AG-1 may serve as a potential means to treat retinal degenerative diseases.
33 ons in CRX have been associated with several retinal degenerative diseases.
34 (rAAV) is a promising vector for therapy of retinal degenerative diseases.
38 gnaling may be especially useful in treating retinal degenerative diseases arising from rhodopsin mis
39 838) were first identified by linkage to the retinal degenerative disease, autosomal dominant cone ro
40 dysfunction plays a central role in various retinal degenerative diseases, but knowledge is limited
44 udy was an autosomal recessive, early-onset, retinal degenerative disease in Persian cats that is lik
48 tion and preventing vision loss secondary to retinal degenerative diseases, including age-related mac
49 the molecular mechanisms underlying certain retinal degenerative diseases, including retinitis pigme
50 to image the macular region in patients with retinal degenerative diseases, including two patients wi
52 as a potential therapeutic strategy to treat retinal degenerative diseases like retinitis pigmentosa
53 potential to restore vision to patients with retinal degenerative diseases like retinitis pigmentosa.
54 The death of photoreceptor cells caused by retinal degenerative diseases often results in a complet
55 d retinal vascular disease; gene therapy for retinal degenerative disease; regenerative medicine, inc
58 sion of Bcl-2 in photoreceptors of mice with retinal degenerative disease slows progression of the di
59 tages of RP is very similar to that of other retinal degenerative diseases such as age-related macula
60 bind sigmaR1 ligands may prove beneficial in retinal degenerative diseases such as diabetic retinopat
63 ed with Leber congenital amaurosis, a severe retinal degenerative disease that causes blindness durin
64 Age-related macular degeneration (AMD) is a retinal degenerative disease that is the leading cause o
66 Leber's congenital amaurosis, a progressive retinal degenerative disease that severely impairs sight
67 restoring functional vision in patients with retinal degenerative diseases, the eyes of blind human s
68 restoring functional vision in patients with retinal degenerative diseases, USC/Second Sight Medical
71 d retinitis pigmentosa is a severe inherited retinal degenerative disease with a frequency of 1 in 10
72 kinetic profile for the treatment of chronic retinal degenerative diseases without systemic exposure.
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。